Clover Health Investments, Corp. (CLOV)
Healthcare · NMS
Price as at 30 Sept 2026, 17:05 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
Clover Health Investments, Corp. trades at $4.40, which is 62% above the $1.67 our fair value estimate puts on the business. On that measure it screens as expensive, which is not the same as saying it will fall.
Our moat model scores it 20 out of 100, which is little in the way of a moat. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.
CLOV earnings and analyst estimates
Recommendation mix, 3 published ratings
Estimates are the published analyst consensus and move often. An earnings date is scheduled, not certain, and a share tends to reprice most violently on the day itself.
About Clover Health Investments, Corp.
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
CLOV passes 2 of our 30 screens today
Each screen prints the exact criteria it used, and the circumstances in which it is wrong.
Super investor ownership
8 of the funds we track reported a position in their latest SEC 13F filing. Largest first:
- Renaissance Technologies, RENAISSANCE TECHNOLOGIES LLC$14.71M · 0.0% of book
- Ken Griffin, CITADEL ADVISORS LLC$11.34M · 0.0% of book
- D. E. Shaw, D. E. Shaw & Co., Inc.$10.30M · 0.0% of book
- Marshall Wace, MARSHALL WACE, LLP$8.19M · 0.0% of book
- Israel Englander, MILLENNIUM MANAGEMENT LLC$5.81M · 0.0% of book
A word of warning on reading these figures: a 13F reports the market value of a holding, so a fund that traded nothing at all still appears to have sold when the price fell. We found 102 companies where the standard reading gives the opposite answer. Only the share count is honest.
CLOV peers
The largest companies in the same industry (Healthcare Plans), then in the same sector.
- UNH UnitedHealth Group Incorporated
- CVS CVS Health Corporation
- MOH Molina Healthcare, Inc.
- OSCR Oscar Health, Inc.
- PGNY Progyny, Inc.
- MRAI Marpai, Inc.
- NOVO-B.CO Novo Nordisk
- LLY Eli Lilly and Company
Every healthcare company we cover is on the Healthcare hub.
Common questions
Is Clover Health Investments, Corp. (CLOV) undervalued?
Against our fair value estimate of $1.67, CLOV at $4.40 is 62% above fair value. That is one model's answer, not a recommendation. It is built from normalized earning power with growth capped deliberately low, which understates companies whose value is mostly future growth.
Which funds own CLOV?
8 of the institutions we track reported a position in CLOV in their most recent SEC 13F filing. A 13F is filed up to 45 days after quarter end, so it tells you what a fund held then, not what it holds now.
Where does SteadyShares get its CLOV data?
Fundamentals for CLOV come from company filings and exchange data, as listed on NMS; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 30 Sept 2026, 17:05 UTC and is delayed. Our data quality score for this company is 75/100, which is the share of the inputs behind our scores that were actually available rather than assumed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for CLOV, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.